HEMATOLOGY ANALYZER MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Market Size and Trends

The hematology analyzer market is estimated to be valued at USD 4.94 Bn in 2024 and is expected to reach USD 8.07 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 7.3% from 2024 to 2031.

To learn more about this report, request a free sample copy

The hematology analyzer market is expected to witness positive growth over the forecast period. Some of the key factors such as the rising prevalence of blood disorders and cancer, increasing demand for accurate hematology testing, and technological advancements in hematology analyzers are expected to support market growth. Additionally, growing geriatric population is expected to contribute to the market growth as they are more prone to develop blood disorders like leukemia and lymphoma. However, high cost of hematology analyzers and lack of skilled laboratory professionals in developing countries may hinder the market growth to some extent during the forecast period.

Rising prevalence of blood disorders

The global hematology analyzer market growth is being driven by the rising prevalence of various blood disorders across the world. Blood disorders pose a major health concern as their occurrence continues to grow steadily over the years. Some of the common blood disorders include anemia, blood cancers, coagulation disorders, and hemophilia. The high anemia prevalence can primarily be attributed to iron deficiency caused by inadequate dietary intake of iron. Apart from anemia, the incidences of various blood cancers like leukemia, lymphoma, and myeloma have also witnessed a rising trend globally. Moreover, genetic coagulation disorders such as hemophilia A and B that impairs the body's ability to control bleeding are also impacting millions worldwide. The increasing patient pool suffering from diverse blood-related health issues has tremendously boosted the demand for hematology analyzers. Right diagnosis plays a pivotal role in timely and effective treatment of blood disorders. Hematology analyzers enable comprehensive blood profiling delivering accurate results to aid in diagnosis of disorders, thus driving the market growth.

Another key factor propelling the hematology analyzer market growth is the world's steadily expanding aging demographic. Population aging is occurring at an unprecedented rate in both developed and developing regions due to continued gains in life expectancy and declining fertility levels. Aged people generally above the age of 65 years comprise the major consumer base that demands frequent medical monitoring and testing services. This is owing to the higher susceptibility of elderly to developing chronic health conditions and age-related diseases. Blood disorders manifesting in later life stages like anemia, blood cancers, and bleeding/clotting aBNormalities require continued surveillance. With people living longer globally, a huge retired population dependent on healthcare has emerged. Regular health checkups along with monitoring of existing conditions through routine blood investigations have become integral to managing the health of senior consumers.